10-year trial of melanoma vaccine shows most promising outcomes to date

Researchers at the University of Adelaide have discovered a new trial vaccine which offers the most promising treatment to date for advanced melanoma.

Known as ‘vaccinia melanoma cell lysate’ (VMCL), this new trial treatment was given regularly to 54 South Australian patients with advanced, inoperable melanoma over a 10-year period. The vaccine has been found to increase patient survival rates, with the ability to stop or reverse the cancer in some patients.

Continue reading “10-year trial of melanoma vaccine shows most promising outcomes to date”

Professor Frazer seeks vaccine for skin cancer

Professor Ian FrazerChair of the ACRF Medical Research Advisory committee (and co-creator of the cervical cancer vaccine), Professor Ian Frazer is currently working on a world-first strategy to combat skin cancer.

“This group of cancers (skin cancers)…may be started off by a virus infection – which presents a great opportunity, because the idea of vaccinating to prevent a cancer is enormously appealing,” Professor Frazer said.

Professor Frazer believes some virus types, including the wart virus or HPV, are embedded in the layers of the skin, and they pose a skin cancer risk when people with damaged or weak immune systems are overexposed to the sun. Continue reading “Professor Frazer seeks vaccine for skin cancer”